AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,782.00p
   
  • Change Today:
      82.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.66m
  • Volume: 1,034,912
  • Market Cap: £167,192m
  • RiskGrade: 123

News - Newspapers

BayArea.com    Chicago Tribune    Daily Mail    Daily Record    Evening Standard    Financial Times    Guardian    Independent on Sunday    Irish Independent    LA Times    Mail on Sunday    New York Times    News Of The World    Nothing Ventured.com    Observer    Scotland on Sunday    Sun    Sunday Express    Sunday Herald    Sunday Telegraph    The Herald    The Independent    The Scotsman    This is Oxfordshire    This is Staffordshire    Times    USA Today    Wall Street Journal    Washington Post   

Tips

Daily Record    Financial Times    Investors Chronicle    Investors Week    LA Times    Mirror    Scotland on Sunday    Shares Magazine    Sunday Business    Sunday Herald    The Herald    The Scotsman    Times    Wall Street Journal   

Analysis

BreakingViews    Citywire    Daily Record    Evening Standard    Financial Times    FT Investor    Global Fund Analysis    Global Fund News    ii-Q.com    Intl Herald Tribune    Intl Herald Tribune    Investors Week    itruffle    LA Times    MoneyGuru    Motley Fool UK    netimperative    Nothing Ventured.com    Nothing Ventured.com    Scotland on Sunday    ShareCast    Sky News    Sunday Herald    Telegraph    The Guild Investor    The Herald    The Register    The Scotsman    Times    TrustNet    UK-iNvest.com    Wall Street Journal   

News - Broadcasters

ABC News    BBC News    CNN    CNN fn   

News - Wires

AFX    Bloomberg UK    Business Wire    BusinessWire    Canada NewsWire    CommentWire    Market Eye    PA NewsCentre    PR Newswire    Reuters    UK-Wire   

News - Internet News

dotPharmacy    GroceryNetwork    Gulf News    Handy Tel    icbirmingham.co.uk    JustFood.com    Money Marketing    News Now    News Review    Nothing Ventured.com    Proactive Investors    The Deal    The451    This Is Money    Vnunet    ZDNet UK   

Bulletin Board Messages

E*Trade    Hemscott.net    iii.co.uk    Market Eye    moneywhispers    Motley Fool UK    Raging Bull    UK Shares    Yahoo   

Search Engines

Altavista    Infoseek UK    Lycos UK    Microsoft Network    UK Index    Webcrawler   

Other Information

Thompson    Yellow Pages   

Press Releases

Hugin    PR Newswire    PRweb   

News - Trade Press

10meters    3gnewsroom    Accountancy Age    American Journal of Transportation    AMM.com    ATW    Aviation International News    BioPortfolio    BioWorld    Campaign    Chain Store Age    Computer Headline    Conclusions Online    Drapers Record    DSN Retailing Today    eFinancial News    Europemedia.net    Financial Planning    Financial Services Review    Fleet Owner    Heavy Duty Trucking    Industrial Distribution    Institutional Investor    Insurance Journal    Insurance Window    Investment News    Investment Policy    Land Line    Landings    mad.co.uk    Marketing    Media Central    Media Life    Media Week Online    Metalbulletin.com    networknews    New Media Age    PR Week    Professional Broking    Reinsurance News    Restructuring Today    Retail Week    Risk and Insurance    Rough Notes    TechWeb    The Daily Planet    The Deal    The Write News    Total Telecom    Trucker    Wired   

Broker Research Notes

Equity Investigator    Multex Investor UK   

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,782.00p
Change Today 82.00p
% Change 0.77 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 1,034,912
Shares Issued 1,550.66m
Market Cap £167,192m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average93.77% below the market average
91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average91.3% below the sector average
Price Trend
17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average17.05% below the market average
30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average30.43% above the sector average
Income
61.92% below the market average61.92% below the market average61.92% below the market average61.92% below the market average61.92% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.35% above the market average86.35% above the market average86.35% above the market average86.35% above the market average86.35% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 06-Jun-2025

Time Volume / Share Price
16:27 0 @ 10,764.00p
16:15 0 @ 10,764.00p
16:08 0 @ 10,756.00p
16:26 14 @ 10,766.00p
16:25 3 @ 10,768.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page